Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bioequivalence study of pitavastatin calcium tablets in healthy Chinese male volunteers
ChiCTR-TTRCC-13003973Phase 4Completed
- Sponsor
- Second Affiliated Hospital of Tianjin University of Traditional Chinese Medicine
- Start
- Oct 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of pitavastatin in hyperlipidemia (3 arms), sponsored by Second Affiliated Hospital of Tianjin University of Traditional Chinese Medicine. Primary endpoints: Plasma concentration of pitavastatin calcium, Pharmacokinetics and relative bioavailability and 1 more. Started Oct 2013; status: completed.
02
Drugs
pitavastatin
03
Conditions
hyperlipidemia
Beyond the preview
Go deeper on ChiCTR-TTRCC-13003973.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-TTRCC-13003973.